Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Clinical trial NCT01680341 · COMPLETED
Trial details
- NCT number
- NCT01680341
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-31
- Primary completion
- 2013-08-22
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.